[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-564742-105":53,"doc-detail-564742-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","icaap-adhd-preschool_medflowchart-final-medication-dosing-and-clinical-notes","ICAAP-ADHD-Preschool_MedFlowChart-FINAL - Medication Dosing and Clinical Notes","","Medication flow chart listing ADHD drug options for preschool-aged patients, organized by line and drug class (stimulants such as methylphenidate, dexmethylphenidate, and amphetamines; non-stimulant alpha agonists such as clonidine and guanfacine). Includes starting and effective dose ranges, daily dosing guidance, formulation availability (tablet, liquid, chewable), and key clinical pearls. Provides cautionary notes on discontinuation speed, need to review family/child heart history, and adjustments for sleep disturbance or coexisting significant diagnoses.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":36,"@type":70,"position":76},"https://docshare.wps.com/template/forms/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/icaap-adhd-preschool_medflowchart-final-medication-dosing-and-clinical-notes/564742/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/icaap-adhd-preschool_medflowchart-final-medication-dosing-and-clinical-notes/564742.png","ImageObject",442,249,{"name":88,"@type":89},"Syukur Setiap Hari","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-16","2026-10-12",true,{"@type":98,"interactionType":99,"userInteractionCount":73},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"Which ADHD medications are included in the chart?","Question",{"text":108,"@type":109},"The chart lists stimulant options (methylphenidate, dexmethylphenidate, and several amphetamine formulations) and non-stimulants (clonidine and guanfacine).","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What dose guidance does the chart provide?",{"text":113,"@type":109},"It provides starting dose information and effective daily dose ranges, including adjustments based on patient factors and sleep disturbance guidance.",{"name":115,"@type":106,"acceptedAnswer":116},"What clinical cautions are highlighted?",{"text":117,"@type":109},"It emphasizes reviewing family/child history of heart conditions, notes on medication discontinuation, and the need to taper if discontinuation is planned.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},564742,1792180772,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":35,"category_name":36,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":73,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":73,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":9},962093541965,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Average  \nDrug Name & Class Starting E ective Max Formulations Clinical Pearls  \nDose Daily Dose Dose Daily  \nSecond Line  \nMethylphenidate (Methylin®) Short-Acting  \nStimulant  \nMethylphenidate (Ritalin®) Short-Acting  \nStimulant  \nDexmethylphenidate (Focalin XR®) Long-Acting  \nStimulant  \nThird Line  \nAmphetamine (Adderall®) Short-Acting  \nStimulant  \nAmphetamine (Eveko®) Short-Acting  \nStimulant  \nAmphetamine (Procentra®) Short-Acting  \nStimulant  \nAmphetamine (Zenzedi®) Short-Acting  \nStimulant  \nFourth Line  \nClonidine (Catapres®, Kapvay®) Alpha Agonist  \nNon-Stimulant  \nGuanfacine (Tenex®, Intuniv®) Alpha Agonist  \nNon-Stimulant  \n1.5 mg  \n1.5 mg  \n2.5 mg  \n0.5-2.5 mg  \n0.5-2.5 mg  \n0.5-2.5 mg  \n0.5-2.5 mg  \n0.025-0.05 mg  \n0.5 mg/day with a  \n0.5 mg increment every third day  \n0.3 mg/kg  \n0.3 mg/kg  \n5 mg  \n0.3 mg/kg  \n0.3 mg/kg  \n0.3 mg/kg  \n0.3 mg/kg  \n.05-.08 mg  \n0.05-0.08 mg/kg  \n\u003C 25kg: 35mg/d >25kg: 60mg/d  \n\u003C 25kg: 35mg/d >25kg: 60mg/d  \n5 mg  \n40 mg  \n40 mg  \n40 mg  \n40 mg  \n0.3 mg administered in divided doses  \nTherapeutic dosage of between  \n1-3 mg/day  \nAvailable in tablet that is chewable or liquid  \nAvailable in tablet and liquid  \nAvailable in tablet: can be crushed and mixed with liquid  \nAvailable in tablet: can be crushed and mixed with liquid  \nAvailable in tablet  \nAvailable in liquid  \nAvailable in tablet  \nAvailable in tablet  \nAvailable in tablet and liquid  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nImmediate release/short acting more e ectivein younger kids.  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nMedication can be discontinued quickly;  \nReview family/child history of heart conditions  \nMax dose for ADHD with sleep disturbance: up to 0 .3mg in divided doses including a bedtime dose  \nA higher dosing range may be needed if there are other signi􀀝cant diagnoses  \nIf discontinuation is planned, these medications must be decreased slowly in increments.  \nA higher dosing range may be needed if there are other signi􀀝cant diagnoses","cbCaisxyYSWcZ28C","https://ap.wps.com/l/cbCaisxyYSWcZ28C","pdf",911933,"English","# Medication and dosage overview\n## Stimulant options by line\n## Non-stimulant options and dosing notes","[{\"question\":\"Which ADHD medications are included in the chart?\",\"answer\":\"The chart lists stimulant options (methylphenidate, dexmethylphenidate, and several amphetamine formulations) and non-stimulants (clonidine and guanfacine).\"},{\"question\":\"What dose guidance does the chart provide?\",\"answer\":\"It provides starting dose information and effective daily dose ranges, including adjustments based on patient factors and sleep disturbance guidance.\"},{\"question\":\"What clinical cautions are highlighted?\",\"answer\":\"It emphasizes reviewing family/child history of heart conditions, notes on medication discontinuation, and the need to taper if discontinuation is planned.\"}]","ICAAP-ADHD-Preschool_MedFlowChart-FINAL - Medication Dosing and Clinical Notes | PDF",1791843934]